Literature DB >> 19714610

International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.

Vinod Chandran1, Alice Gottlieb, Richard J Cook, Kristina Callis Duffin, Amit Garg, Philip Helliwell, Arthur Kavanaugh, Gerald G Krueger, Richard G Langley, Charles Lynde, Neil McHugh, Philip Mease, Ignazio Olivieri, Proton Rahman, Cheryl F Rosen, Carlo Salvarani, Diamant Thaci, Sergio M A Toloza, Maxine Yat Wing Wong, Qian M Zhou, Dafna D Gladman.   

Abstract

OBJECTIVE: Clinical trials in psoriasis and psoriatic arthritis (PsA) involve assessment of the skin and joints. This study aimed to determine whether assessment of the skin and joints in patients with PsA by rheumatologists and dermatologists is reproducible.
METHODS: Ten rheumatologists and 9 dermatologists from 7 countries met for a combined physical examination exercise to assess 20 PsA patients (11 men, mean age 51 years, mean PsA duration 11 years). Each physician assessed 10 patients according to a modified Latin square design that enabled the assessment of patient, assessor, and order effect. Tender joint count (TJC), swollen joint count (SJC), dactylitis, physician's global assessment (PGA) of PsA disease activity (PGA-PsA), psoriasis body surface area (BSA), Psoriasis Area and Severity Index (PASI), Lattice System Physician's Global Assessment of psoriasis (LS-PGA), National Psoriasis Foundation Psoriasis Score (NPF-PS), modified Nail Psoriasis Severity Index (mNAPSI), number of fingernails with nail changes (NN), and PGA of psoriasis activity (PGA-Ps) were assessed. Variance components analyses were carried out to estimate the intraclass correlation coefficient (ICC), adjusted for the order of measurements.
RESULTS: There is excellent agreement (ICC >/=0.80) on the mNAPSI, substantial agreement (0.6 >/= ICC < 0.80) on the TJC, PASI, and NN, moderate agreement (0.4 >/= ICC < 0.60) on the PGA-Ps, LS-PGA, NPF-PS, and BSA, and fair agreement (0.2 >/= ICC < 0.40) on the SJC, dactylitis, and PGA-PsA. The only measure that showed a significant difference between dermatologists and rheumatologists was dactylitis (P = 0.0005).
CONCLUSION: There is substantial to excellent agreement on the TJC, PASI, NN, and mNAPSI among rheumatologists and dermatologists.

Entities:  

Mesh:

Year:  2009        PMID: 19714610     DOI: 10.1002/art.24562

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  17 in total

1.  [Diagnosis and therapy of early psoriatic arthritis].

Authors:  M Köhm; F Behrens
Journal:  Z Rheumatol       Date:  2012-01       Impact factor: 1.372

2.  Joint count reliability in psoriatic arthritis observational trials--an unreported problem.

Authors:  William Tillett; Gavin Shaddick; Eleanor Korendowych; Corinne S de Vries; Neil McHugh
Journal:  Rheumatology (Oxford)       Date:  2012-05-04       Impact factor: 7.580

Review 3.  Application of the GRAPPA psoriatic arthritis treatment recommendations in clinical practice.

Authors:  Aizad Mumtaz; Oliver FitzGerald
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

4.  Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study.

Authors:  Ismihan Sunar; Sebnem Ataman; Kemal Nas; Erkan Kilic; Betul Sargin; Sevtap Acer Kasman; Hakan Alkan; Nilay Sahin; Gizem Cengiz; Nihan Cuzdan; Ilknur Albayrak Gezer; Dilek Keskin; Cevriye Mülkoğlu; Hatice Resorlu; Ajda Bal; Mehmet Tuncay Duruöz; Okan Küçükakkaş; Ozan Volkan Yurdakul; Meltem Alkan Melikoglu; Yıldıray Aydın; F Figen Ayhan; Hatice Bodur; Mustafa Calis; Erhan Capkın; Gul Devrimsel; Kevser Gok; Sami Hizmetli; Ayhan Kamanlı; Yaşar Keskin; Hilal Kocabas; Oznur Kutluk; Nesrin Şen; Omer Faruk Şendur; Ibrahim Tekeoğlu; Sena Tolu; Murat Toprak; Tiraje Tuncer
Journal:  Rheumatol Int       Date:  2019-11-26       Impact factor: 2.631

5.  Which Psoriasis Patients Develop Psoriatic Arthritis?

Authors:  Kristine Busse; Wilson Liao
Journal:  Psoriasis Forum       Date:  2010

6.  Patterns of peripheral joint involvement in psoriatic arthritis-Symmetric, ray and/or row?

Authors:  Vinod Chandran; Lynne Stecher; Vern Farewell; Dafna D Gladman
Journal:  Semin Arthritis Rheum       Date:  2018-03-09       Impact factor: 5.532

Review 7.  [Psoriatic arthritis. Treatment outcome parameters].

Authors:  E Märker-Hermann; F Behrens
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372

8.  A novel, short, and simple screening questionnaire can suggest presence of psoriatic arthritis in psoriasis patients in a dermatology clinic.

Authors:  N Garg; B Truong; J H Ku; T S Devere; B D Ehst; A Blauvelt; A A Deodhar
Journal:  Clin Rheumatol       Date:  2014-05-15       Impact factor: 2.980

Review 9.  Psoriatic arthritis: pharmacotherapy update.

Authors:  Philip J Mease
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

Review 10.  Treatment recommendations for psoriatic arthritis.

Authors:  C T Ritchlin; A Kavanaugh; D D Gladman; P J Mease; P Helliwell; W-H Boehncke; K de Vlam; D Fiorentino; O Fitzgerald; A B Gottlieb; N J McHugh; P Nash; A A Qureshi; E R Soriano; W J Taylor
Journal:  Ann Rheum Dis       Date:  2008-10-24       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.